
Experts Discuss Opportunities and Challenges for NGS
Next-generation sequencing is reshaping how labs detect, understand, and manage disease
Next-generation sequencing is reshaping how labs detect, understand, and manage disease
Sara Pirzadeh-Miller offers advice on overcoming the reimbursement barriers genetic counselors face in the clinical lab and beyond
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice
How three companies are addressing screening challenges with tests that help improve chances of early detection